Bavarian Nordic Receives Contract Valued At USD 9 Million From Janssen As Part Of Advanced Development Of Prime-Boost Ebola Vaccine Regimen

Bavarian Nordic A/S announced recently the award of a subcontract from Crucell Holland B.V., one of Janssen Pharmaceutical Companies of Johnson & Johnson, valued at USD 9 million.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news